HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AR C117977

inhibits monocarboxylate transporter 1 (MCT1); an immunosuppressant; no further info 1/2008

Also Known As:

AR-C117977

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- AR C117977: 2

Experts

1.	Dasgupta, Abhijit: 1 article (03/2012)
2.	Gandara, Ricardo: 1 article (03/2012)
3.	Lin, Zhao: 1 article (03/2012)
4.	Lisanti, Michael P: 1 article (03/2012)
5.	Martinez-Outschoorn, Ubaldo E: 1 article (03/2012)
6.	Philp, Nancy J: 1 article (03/2012)
7.	Sneddon, Sharon: 1 article (03/2012)
8.	Sotgia, Federica: 1 article (03/2012)
9.	Whitaker-Menezes, Diana: 1 article (03/2012)
10.	Witkiewicz, Agnieszka K: 1 article (03/2012)

Related Diseases

1.	Neoplasms (Cancer) 03/15/2012 - "Similarly, we discuss how stromal MCT4 could be used as a biomarker for identifying high-risk cancer patients that could likely benefit from treatment with FDA-approved drugs or existing MCT-inhibitors (such as, AR-C155858, AR-C117977, and AZD-3965)."
2.	Arteriosclerosis 11/15/2007 - "AR-C117977 also inhibited the development of transplant arteriosclerosis in aortic allografts partially, but was unable to inhibit alloantibody production after transplantation. "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	AR C155858

Related Therapies and Procedures

1.	Transplantation